Data from the Phase III JUNIPERA trial shows more patients with juvenile idiopathic arthritis achieved and maintained improvements in joint symptoms with Cosentyx® (secukinumab).
List view / Grid view
Cincinnati Children's Hospital Medical Center
Research suggests patients who receive COVID-19 vaccines prior to a transplant and subsequent immunosuppression may be protected from the disease.
Researchers in the U.S. and Japan want to use radio frequency identification (RFID) chips keeping track of organoids...